Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
Among those not using a sleep apnea mask, Zepbound was about five times more effective than a placebo at reducing the number of breathing disruptions per hour, the company said. "Zepbound is the ...
Would you please address the dangers of untreated sleep apnea? Also, what do people do when they are unable to tolerate a CPAP (continuous positive airway pressure) machine?